Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Keppra Chromosome Abnormality	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra CNS Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra High Grade Non-Hodgkin's Lymphoma, Adult	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra Intrachromosomal Amplification of Chromosome 21	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra Juvenile Myelomonocytic Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra Monosomy 7	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra NF1 Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra N-RAS Gene Amplification	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra PTPN11 Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra Remission	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra Somatic Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Keppra TP53	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Acute Lymphoblastic Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Acute Leukemia Of Ambiguous Lineage	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Burkitt Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Chronic Myeloid Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Lymphoplasmacytic Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 Myelodysplastic Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Mgta-456 T-Cell Non-Hodgkin Lymphoma	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Monomethyl Fumarate Graft Failure	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Monomethyl Fumarate High Risk Anemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
N-Acetyl-L-Cysteine Acyl-CoA Oxidase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
N-Acetyl-L-Cysteine Adrenoleukodystrophy With Cerebral Involvement	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
N-Acetyl-L-Cysteine Alpha-Mannosidosis	Masonic Cancer Center, University of Minnesota	P2	CCC (53)

Showing 451 to 475 of 705 assets

PreviousPage 19 of 29Next